VIR

Vir Biotechnology, Inc. is a clinical-stage immunology company based in San Francisco, California, specializing in the development of innovative therapeutic solutions for serious infectious diseases. The company leverages its proprietary technologies and a robust pipeline that includes advanced monoclonal antibodies and immunotherapeutics to address significant unmet medical needs, particularly in viral infections like COVID-19 and influenza. Through strategic partnerships and collaborations, Vir enhances its research capabilities and positions itself as a pivotal entity in the biotechnology sector, committed to advancing global health outcomes.